Asia Pacific 3D Printing Medical Devices Market Segments and Growth by 2028

Asia Pacific 3D Printing Medical Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Software and Services, Equipment {3D Printers, 3D Bioprinters}, Materials {Plastics Material, Metal and Metal Alloys, Bioprinting Biomaterial, Wax Material, and Others}), Technology (Laser Beam Melting {Direct Metal Laser Sintering, Selective Laser Sintering, Selective Laser Melting, LaserCusing}, Photopolymerization {Stereolithography, Others}, Droplet Deposition/Extrusion Based Technologies {Fused Deposition Modelling, Multiphase Solidification, Low Temperature Deposition Manufacturing}, Electron Beam Melting ), Application (Custom Prosthetics and Implants {Craniomaxillofacial Implants, Custom Dental Prosthetics and Implants, Custom Orthopedic Implants}, Surgical Guides {Dental Orthopedic, Craniomaxillofacial, Spinal Guides}, Tissue Engineering Products {Bone and Cartilage Scaffolds, Ligament and Tendons Scaffolds}, Surgical Instruments {Surgical Fasteners, Scalpels, Retractors}, Hearing Aids, Wearable Medical Devices, Standard Prosthetics and Implants), and End-User (Hospitals and Surgical Centers, Dental and Orthopedic Centers, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028
  • Report Date : Mar 2022
  • Report Code : TIPRE00027727
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 179
Buy Now  
Asia Pacific 3D Printing Medical Devices Market Segments and Growth by 2028
Report Date: Mar 2022   |   Report Code: TIPRE00027727
Buy Now
Page Updated: Mar 2022

The Asia Pacific 3D printing medical devices market is expected to reach US$ 1,415.5 million by 2028 from US$ 438.8 million in 2021. The market is estimated to grow at a CAGR of 18.2% from 2021–2028.

3D printing technology has emerged as an excellent technique and valuable tool for organ transplantation. The 3D bioprinters have gone through many stages and improvements to meet quality standards and expectations. Thus, the development and production of 3D printers is a continuously growing process, with expanding application range. 3D printers help accelerate medical device production, thereby saving patients’ lives. They help solve the problem of shortages of organ donors and host rejection of donated organs. Moreover, it allows doctors to treat many patients in a short period. Organs cannot survive in the absence of readily available environments that supply blood, oxygen, and essential nutrients. The 3D printing technology can be used to create safe environments for transplanted organs. 3D printers have a significant impact on organ replacement in the medical field because they are bio-printed rather; it saves time spent on searching for suitable donors. As a result, the outcome is expected to be profoundly positive, particularly in terms of quality of life, with significant societal ramifications. Artificial tissue and organ bioprinting are promising applications of 3D bioprinting that have the potential to revolutionize the field of regenerative medicine.

The spread of the COVID-19 pandemic has emphasized health data sharing and interoperability under the microscope. Pediatric coronavirus disease-19 (COVID-19) infection is comparatively mild compared to adults, and children are assigned a better prognosis. The interruptions in the supply chain and the massive demand for efficient treatments for the therapy of COVID-19 have put the health research industry in the Asia-Pacific region in a crucial position. The current medical system is built on private-sector equipment. The majority of medical equipment is patented by medical companies. Suppliers are unable to provide the requisite quantity of equipment in the event of a sudden rise in demand, necessitating innovation and new manufacturing tactics. Furthermore, transportation and trade restrictions, quarantines, border controls, and production disruptions all have a significant impact on the essential medical device supply chain. Fortunately, 3D printing technology may provide a viable answer to this issue. The generated open source designs of medical equipment are freely shared using this technology.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the 3D printing medical devices market. The Asia Pacific 3D printing medical devices market is expected to grow at a good CAGR during the forecast period.

Asia Pacific 3D Printing Medical Devices Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific 3D Printing Medical Devices Market Revenue and Forecast to 2028 (US$ Million)

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Asia Pacific 3D Printing Medical Devices Market Segmentation

By Component  

  • Software and Services
  • Equipment
    • 3D Printers
    • 3D Bioprinters
  • Materials
    • Plastics Material
    • Metal and Metal Alloys
    • Bioprinting Biomaterials
    • Wax
    • Others

By Technology

  • Laser Beam Melting
    • Direct Metal Laser Sintering
    • Selective Laser Sintering
    • Selective Laser Melting
    • LaserCusing
  • Photopolymerization
    • Stereolithography
    • Others
  • Droplet Deposition/Extrusion Based Technologies
    • Fused Deposition Modelling
    • Multiphase Solidification
    • Low Temperature Deposition Manufacturing
  • Electron Beam melting

By Application

  • Custom Prosthetics and Implants
    • Craniomaxillofacial Implants
    • Custom Dental Prosthetics and Implants
    • Custom Orthopaedic Implants
  • Surgical Guides
    • Dental Guides
    • Orthopaedic Guides
    • Craniomaxillofacial Guides
    • Spinal Guides
  • Tissue Engineering Products
    • Bone and Cartilage Scaffolds
    • Ligaments and Tendons Scaffolds
  • Surgical Instruments
    • Surgical Fasteners
    • Scalpels
    • Retractors
  • Hearing Aids
  • Wearable Medical Devices
  • Standard Prosthetic and Implants
  • Others

By End-User

  • Hospitals and Surgical Centres
  • Dental and Orthopaedic Centres
  • Medical Device Companies
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others

By Country

  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Companies Mentioned

  • EOS GmbH Electro Optical Systems
  • Renishaw PLC
  • Stratasys Ltd.
  • 3D Systems, Inc.
  • EnvisionTech, Inc.
  • Concept Laser Gmbh (General Electric)
  • SLM Solution Group AG
 

Asia Pacific 3D Printing Medical Devices Report Scope

Report Attribute Details
Market size in 2021 US$ 438.8 Million
Market Size by 2028 US$ 1,415.5 Million
CAGR (2021 - 2028) 18.2%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Component
  • Software and Services
  • Equipment
  • Materials
By Technology
  • Laser Beam Melting
  • Photopolymerization
  • Droplet Deposition/Extrusion Based Technologies
  • Electron Beam Melting
By Application
  • Custom Prosthetics and Implants
  • Surgical Guides
  • Tissue Engineering Products
  • Surgical Instruments
  • Hearing Aids
  • Wearable Medical Devices
  • Standard Prosthetics and Implants
By End-User
  • Hospitals and Surgical Centers
  • Dental and Orthopedic Centers
  • Medical Device Companies
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • EOS GmbH Electro Optical Systems
  • Renishaw PLC
  • Stratasys Ltd.
  • 3D Systems, Inc.
  • EnvisionTech, Inc.
  • Concept Laser Gmbh (General Electric)
  • SLM Solution Group AG
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA